Collins, G. P., Eyre, T. A., Schmitz-Rohmer, D., Townsend, W., Popat, R., Giulino-Roth, L., Fields, P. A., Krasniqi, F., Soussain, C., Stathis, A., Andjelkovic, N., Cunningham, D., Mandic, D., Radulovic, S., Tijanic, I., Horowitz, N. A., Kurtovic, S., Schorb, E., Schmidt, C., Dimitrijević, S., & Dreyling, M. (2021). a Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma. HemaSphere, 5(11), e656–. http://access.bl.uk/ark:/81055/vdc_100145485964.0x000007